Form 4: AtriCure Executive Noznesky Reports Stock Transactions

Justin J. Noznesky, Chief Marketing & Strategy Officer of AtriCure, Inc., reports acquisition and disposal of company stock.

Summary

• On March 1, 2025, Justin J. Noznesky, Chief Marketing & Strategy Officer of AtriCure, Inc., reported transactions involving AtriCure common stock.
• Noznesky acquired 19,359 shares through a Restricted Stock Award and 6,579 shares through the vesting of a Performance Share Award, both under the company's 2023 Stock Incentive Plan.
• He also disposed of 9,673 shares to satisfy tax withholding obligations at a price of $38.74 per share.
• Following these transactions, Noznesky beneficially owns 86,964 shares of AtriCure common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment. This is a standard regulatory filing reflecting stock transactions by an officer. The transactions themselves don't necessarily indicate a positive or negative outlook.

Positives

• The vesting of performance shares suggests that the company met certain performance goals.

Negatives

• The disposal of shares to cover tax obligations could be interpreted as a slightly negative signal, although it's a common practice.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders may be interested in the insider's transactions as an indicator of management's view of the company's stock.

Key Dates

Keywords

AtriCure, Stock Incentive Plan, Form 4, Beneficial Ownership, Noznesky, Stock Transactions, Restricted Stock Award, Performance Share Award